Title:
Ｒ−ケタミンおよびその塩の医薬品としての応用
Document Type and Number:
Japanese Patent JP6615277
Kind Code:
B2
Abstract:
Provided is a novel compound having rapid and long-lasting therapeutic effects on diseases exhibiting depressive symptoms. Specifically, provided are an agent for prevention and/or treatment of a depressive symptom, consisting of R(-)-ketamine or a pharmacologically acceptable salt thereof, and a pharmaceutical composition for prevention and/or treatment of a depressive symptom, comprising R(-)-ketamine or a pharmacologically acceptable salt thereof in an effective amount for reducing a depressive symptom, and being substantially free of S(+)-ketamine, and a pharmacologically acceptable salt thereof
Inventors:
Kenji Hashimoto
Application Number:
JP2018126684A
Publication Date:
December 04, 2019
Filing Date:
July 03, 2018
Export Citation:
Assignee:
National University Corporation Chiba University
International Classes:
A61K31/135; A61P25/24
Domestic Patent References:
| JP2015078181A |
Foreign References:
| US20120225949 | ||||
| WO2011020061A1 |
Other References:
ACTA ANAESTHESIOLOGICA SCANDINAVICA,2005年,Vol.49,pp.1436-1442,DOI:10.1111/j.1399-6576.2005.00838.x
Journal of Palliative Mecdicine,2013年 8月,Vol.16, No.8,pp.958-965,DOI:10.1089/jpm.2012.0617
The World Journal of Biological Psychiatry,2009年,Vol.10, No.3,pp.241-244,DOI:10.1080/15622970701714370.
ANNA Jounal,2013年 4月,Vol.81, No.2,pp.118-119
Journal of Palliative Mecdicine,2013年 8月,Vol.16, No.8,pp.958-965,DOI:10.1089/jpm.2012.0617
The World Journal of Biological Psychiatry,2009年,Vol.10, No.3,pp.241-244,DOI:10.1080/15622970701714370.
ANNA Jounal,2013年 4月,Vol.81, No.2,pp.118-119
Attorney, Agent or Firm:
Takashi Shoji
Yuriko Shinobu
Takuya Osugi
Yuriko Shinobu
Takuya Osugi